alexa Editor - Kamalakannan Palanichamy | The Ohio State University | 23473
ISSN: 2576-1447

Journal of Cancer Science and Research
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Kamalakannan Palanichamy

Kamalakannan Palanichamy
Dr Kamalakannan Palanichamy Assistant Professor, Department of Radiation Oncology The Ohio State University College of Medicine / Comprehensive Cancer Center Ohio,USA
The Ohio State University

Biography

I obtained my B.S, Chemistry, Madurai Kamaraj University, India. Has done M.S, Applied Chemistry and Phd Bio-Inorganic Chemistry, National Institute of Technology, Bharathidasan University, India. Was Post-Doctoral Research Associate in Massachusetts General Hospital / Harvard Medical School, Boston. Currently Assistant Professor, Department of Radiation Oncology The Ohio State University College of Medicine / Comprehensive Cancer Center.

Research Interest

My research focus is to bridge the gap between basic and clinical research. To this end, we explore transcriptomic, epigenetic, metabolomic, proteomic and genomic profiles in patient tumor biopsy samples to identify predictive and prognostic markers and validate therapeutic targets using pre-clinical models. We are also working to identify the underlying mechanisms of chemo and radiation resistance in treatment-refractory tumors by short-circuiting signal transduction pathways and determining the mutational status, gene and molecular signatures mediating treatment resistance. We have developed cancer stem cell models to investigate cancer stem cell biology via protein-protein interactions at translational and transcriptional levels. We are conducting correlative biology studies in patient cohorts to determine whether a particular gene, protein, or metabolite contributes to progression free survival, overall survival, and toxicity.

Certificate

Certificate
Leave Your Message 24x7
Top